Afuco™ Anti-BSG ADCC Therapeutic Antibody (Ziralimumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human CD147. Ziralimumab is a human monoclonal antibody which is used as an immunosuppressive drug.
Supplier Creative Biolabs
Product # AFC-TAB-883
Pricing Inquiry
Host Human
Target BSG
Species Reactivity Human
Type ADCC enhanced antibody
Applications IF, IP, Neut, FuncS, ELISA
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback